įu P, Wang CQ, Yu H, Xu HM, Jing CM, Deng JK, et al.
Antimicrobial resistance profile of clinical isolates in pediatric hospitals in China: report from the ISPED Surveillance Program, 2017. CrossRefįu P, Wang CQ, Yu H, Xu HM, Jing CM, Deng JK, et al. Incidence and outcomes of infections caused by multidrug-resistant Enterobacteriaceae in children, 2007-2015. Surveillance of bacterial resistance in children and newborns across China from 2014 to 2017.
Li SG, Hu FP, Zhou C, Xu XS, Fu CW, Liu XL, et al. The growing threat of antibiotic resistance in children. Rong Zhang, Online Date: November 19 2021 The First Affiliated Hospital of Zhejiang University, Zhejiang University, Hangzhou, Zhejiang, Chinaĭepartment of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong Special Administrative Region, China Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, Chinaĭepartment of Clinical Laboratory, the Affiliated Hospital of Hangzhou Normal University, Hangzhou, Zhejiang, Chinaĭepartment of Clinical Laboratory, Hangzhou Women’s Hospital, Hangzhou Maternity and Child Health Care Hospital, Hangzhou, Zhejiang, ChinaĬlinical Diagnostic Laboratory, People’s Hospital of Zhejiang, Hangzhou, Zhejiang, Chinaĭepartment of Clinical Laboratory, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China National Clinical Research Center for Child Health, the Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, Chinaĭepartment of Hospital Infection Control, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, Chinaĭepartment of Clinical Laboratory, the Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, Chinaĭepartment of Laboratory Medicine, the First Affiliated People’s Hospital of Hangzhou, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China Master of Science, New Jersey Institute of Technology, Newark, New Jersey, the United States of America Multidrug-resistant bacteria prevention and control strategies should be adjusted in a timely manner based on the surveillance results.ĭepartment of Clinical Laboratory, the Second Affiliated Hospital of Zhejiang University, Zhejiang University, Hangzhou, Zhejiang, ChinaĬlinical Microbiology Laboratory, the Third People’s Hospital of Hangzhou, Hangzhou, Zhejiang, ChinaĬhina Australia Joint Laboratory for Animal Health Big Data Analytics, College of Animal Science and Technology, Zhejiang Agricultural and Forestry University, Hangzhou, Zhejiang, China Conclusionsĭespite an overall decrease in the prevalence of drug-resistant bacteria in 2019, the rising prevalence of MRSA and CRPA still warrant much attention. The prevalence of ESBL-E and CRE decreased since 2015 but that of CRPA and MRSA increased from 2014 to 2018. The prevalence of these key pathogens was lower than that reported in the national surveillance system (China Antimicrobial Resistance Surveillance System and Infectious Diseases Surveillance of Pediatrics). The prevalence of extended spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E), carbapenem-resistant Enterobacteriaceae (CRE), carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant Pseudomonas aeruginosa (CRPA), and methicillin-resistant Staphylococcus aureus (MRSA) were 40.6%, 2.3%, 14.7%, 9.0%, and 27.4%, respectively. Resultsįrom 2014 to 2019, a total of 30,163 multidrug-resistant strains were identified among 212,252 clinical isolates. Statistical analysis was performed to analyze the pattern of distribution of five key bacterial pathogens in different age groups, ward settings, and bloodstream infections. Patient data were collected from the Annual Review of Hospital Infection Resistance Survey in Zhejiang Province, 2014–2019. In Zhejiang Province, China, the trends of drug-resistance in non-adult patients from 2014 to 2019 were monitored, aiming to determine the variation patterns and epidemiological features of MDR strains. The prevalence of multidrug-resistant (MDR) bacterial infections increased substantially among inpatients under 18 years of age in recent years. Antimicrobial resistance has become a major public health threat globally.
0 kommentar(er)
